Vitamin B2 (Riboflavin) for Cognitive Function
Verdict: No proven cognitive benefit; evidence insufficient
There is no randomized evidence that taking vitamin B2 (riboflavin) improves cognition or prevents age-related cognitive decline; the only supportive data are observational, so the verdict is Unverified (insufficient evidence) rather than a recommendation to supplement.
U ⚫ U Unverified Insufficient Evidence
Why this grade7-layer evidence engine
This grade reflects a sharp evidence gap. Every quantitative cognitive finding for riboflavin comes from observational studies, and not a single randomized trial has tested B2 on its own with cognition as an endpoint. Observational signals are reasonably consistent: in the Irish TUDA cohort the poorest riboflavin status was the strongest B-vitamin predictor of cognitive dysfunction (PMID 40717068, n=4,553, adjusted OR 1.73), with a reported 53% higher risk in people carrying the MTHFR 677TT genotype plus low riboflavin (PMID 27854316). Higher dietary intake also tracked with better scores in a Chinese cohort (PMID 31555120) and two overlapping NHANES analyses (PMID 39012764, PMID 38037028).
Those signals do not survive harder tests. Within the same TUDA cohort, a 4-year prospective sub-sample found riboflavin status did NOT predict cognitive decline (PMID 28075382), hinting at reverse causation or confounding. The proposed homocysteine-lowering mechanism is also weak: a 22,000-person individual-patient meta-analysis showed B-vitamin supplementation had no meaningful effect on cognition (PMID 24965307), and a 2025 review of 17 B-vitamin RCTs found at most a tiny pooled benefit with none isolating B2 (PMID 40966571).
Authorities reinforce the cautious read. EFSA recognizes only riboflavin's basic biochemical role in normal nervous-system function, not any cognitive treatment claim, and the NHS says diet supplies enough and that high-dose effects are unproven. Clinical societies decline to endorse it for the brain, and the Alzheimer's Association states plainly that no supplement has been proven to benefit cognitive function or brain health. The defensible takeaway is to meet the riboflavin RDA through food, not to use B2 as a brain supplement.
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.43
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
79%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.433
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
- tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (8)L2 · primary research & systematic reviews
Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction
Finding: Poorer riboflavin status (highest EGRac quartile, worst riboflavin) was independently and strongly associated with cognitive dysfunction: ORadj 1.73 (95% CI 1.44-2.09, p<0.001) - the largest effect among B-vitamins examined. Lower B12 ORadj 1.30 (1.08-1.58, p=0.007), lower B6 ORadj 1.37 (1.12-1.67, p=0.002), higher tHcy ORadj 1.50 (1.22-1.83, p<0.001) were also significant. NOVEL FINDING: ApoE epsilon4 carriage interacted adversely with low B12 (p_int=0.030) and elevated tHcy (p_int=0.008) but NOT with riboflavin (EGRac x ApoE p=0.789). This is the most recent and largest TUDA cognitive analysis and confirms the riboflavin-cognitive dysfunction signal at scale.
View on PubMed Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing (TUDA review with riboflavin x MTHFR 677TT cognitive subgroup data)
Finding: In TUDA, low biomarker status of vitamin B6 and riboflavin were each independent predictors of cognitive dysfunction; combined low B6 + low riboflavin status was associated with a 30-50% increased risk of cognitive dysfunction after adjustment. The MTHFR 677C>T polymorphism alone did NOT associate with cognitive dysfunction, but the homozygous 677TT genotype combined with low riboflavin status was associated with a 53% increased risk of cognitive dysfunction on the RBANS battery - the only gene-nutrient interaction identified for cognition in this cohort. Authors emphasised that no targeted RCT of riboflavin (or B6) for cognitive endpoints in 677TT carriers has yet been performed.
View on PubMed B-Vitamin Intake and Biomarker Status in Relation to Cognitive Decline in Healthy Older Adults in a 4-Year Follow-Up Study
Finding: Mean MMSE declined from 29.1+/-1.3 to 27.5+/-2.4 (p<0.001); ~27% experienced accelerated decline. Lower B6 status (PLP <43 nmol/L) was the strongest predictor of accelerated decline: ORadj 3.48 (95% CI 1.58-7.63, p<0.05); lower dietary B6 (0.9-1.4 mg/d) ORadj 4.22 (1.28-13.90, p<0.05). CRITICALLY: NO significant prospective association was found between baseline riboflavin status (EGRac) or dietary riboflavin and 4-year cognitive decline. The riboflavin-cognition signal in TUDA therefore appears to be cross-sectional / contemporaneous rather than predictive of within-individual decline in a smaller longitudinal sub-sample.
View on PubMed Dietary Intake of Riboflavin and Unsaturated Fatty Acid Can Improve the Multi-Domain Cognitive Function in Middle-Aged and Elderly Populations: A 2-Year Prospective Cohort Study
Finding: Higher dietary riboflavin was associated with better 2-year cognitive performance: global cognition (MoCA) beta = 1.31 (95% CI 0.26-2.35, p=0.015); verbal memory beta = 0.37 (95% CI 0.02-0.71, p=0.038). High-riboflavin subgroup showed less cognitive decline (p=0.004). Unsaturated fatty acid intake gave parallel protective signals. Result is consistent with TUDA cross-sectional findings (PMID 40717068, PMID 27854316) and extends them to a non-Western, non-fortified Chinese population.
View on PubMed Association between dietary riboflavin intake and cognitive decline in older adults: a cross-sectional analysis (NHANES 2011-2014)
Finding: Higher dietary riboflavin intake (highest vs lowest quartile) was associated with significantly LOWER odds of cognitive decline across multiple domains: DSST ORadj 0.53 (95% CI 0.37-0.77); composite Z ORadj 0.56 (0.39-0.80); AFT ORadj 0.68 (0.49-0.96); DR ORadj 0.73 (0.53-1.00, borderline). Dose-response was L-shaped with an inflection point near 2.98 mg/d - close to but slightly above U.S. RDA (1.3 mg/d for men, 1.1 mg/d for women), suggesting most protection accrues when intake exceeds RDA but plateaus thereafter.
View on PubMed Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study (NHANES)
Finding: Higher B2 intake (Q4 vs Q1) was associated with better DSST performance with an implausibly large point estimate (OR 45.1, 95% CI 3.99-510, p=0.004), indicating sparse-data instability - the very wide CI signals that this OR should NOT be interpreted as a magnitude, only as a directional signal. Per-mg increase in B2 intake had a much more credible association with CERAD total score (OR 1.03, 95% CI 1.01-1.04, p=0.003). Associations were stronger in males, non-Hispanic whites, and BMI 18.5-30 kg/m^2. Direction is consistent with PMID 39012764 (also NHANES) and PMID 31555120 (Chinese cohort).
View on PubMed Effects of homocysteine lowering with B vitamins on cognitive aging: IPD meta-analysis of 11 trials (n~22,000)
Finding: B-vitamin allocation lowered tHcy by ~25% but produced NO significant effect on any cognitive domain (memory, processing speed, executive function) or on global cognitive function; estimated effect equivalent to 0.02 years of cognitive aging per year of treatment - clinically meaningless. RELEVANCE TO B2: very few included trials separated riboflavin from the folic-acid/B12 backbone, so this meta-analysis does NOT directly test riboflavin monotherapy. It does, however, establish that the homocysteine-cognition pathway is not a reliable causal route in unselected older adults - which is the proposed mechanism for B2 benefit via the FAD-dependent MTHFR step.
View on PubMed Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults (SR/MA, 17 RCTs)
Finding: Very small pooled benefit on global cognition after outlier exclusion (Hedges g = 0.110, 95% CI 0.034-0.186, I^2 = 15.4%, GRADE high in refined analysis); clinically modest, absent in cognitively healthy subgroup, and disappears with trim-and-fill. The MA is the most recent comprehensive pooled estimate but does NOT isolate riboflavin; it provides a ceiling on plausible B-vitamin cognitive effects relevant to the riboflavin discussion.
View on PubMed Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …
L4a US FDA
Supportive
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established between the dietary intake of riboflavin and (a) contribution to normal energy-yielding metabolism, (b) contribution to normal functioning of the nervous system, (c) maintenance of normal mucous membranes, (d) maintenance of normal red blood cells, (e) maintenance of normal skin, (f) maintenance of normal vision, (g) normal metabolism of iron… source↗
L4c UK NHS
Cautious
Riboflavin (vitamin B2) helps: keep skin, eyes and the nervous system healthy; the body release energy from food. ... Adults (aged 19 to 64) need about: 1.3mg a day of riboflavin for men; 1.1mg a day of riboflavin for women. You should be able to get all the riboflavin you need from your daily diet. Riboflavin cannot be stored in the body, so you need it in your diet every day. ... There's not … source↗
L4d TW TFDA / 衛福部
Supportive
維生素B2有助於維持能量正常代謝；維生素B2有助於維持皮膚的健康 source↗
L4e WHO
Supportive
Riboflavin (vitamin B2) is an essential water-soluble vitamin that functions as a coenzyme in numerous redox reactions. The recommended nutrient intake for adults is 1.3 mg/day for men and 1.1 mg/day for women. source↗
L5a NIH Office of Dietary Supplements
Supportive
L5c Cleveland Clinic
Supportive
Riboflavin (vitamin B2) plays an important role in maintaining the health of your blood cells, brain, skin, and digestive tract. source↗
L5e Specialty Society (condition-mapped)
Against
Not a single food, beverage, ingredient, vitamin or supplement has been proven to prevent, treat or cure Alzheimer's disease or to benefit cognitive function or brain health. source↗